R. Jacob Vogelstein
InvestorManaging Partner at Catalio Capital Management, LP · Board director at NextPoint Therapeutics
Bethesda
Writes $100K – $5M checks · typically $1.5M
About
Jacob Vogelstein co-founded Catalio Capital Management and serves as Managing Partner, focusing on investments in private healthcare companies and sitting on the firm's Nexus strategy Investment Committee and Management Committee. He was previously a General Partner at Camden Partners Holdings, where he invested in biomedical technology, and earlier held faculty positions at Johns Hopkins University's Applied Physics Laboratory and Whiting School of Engineering. He holds a BSc in Bio-Electrical Engineering from Brown University and a PhD in Biomedical Engineering from the Johns Hopkins University School of Medicine.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Board director at NextPoint Therapeutics
Intro paths
→
In turn, R. can intro founders to NextPoint Therapeutics's investors below.
NextPoint Therapeutics's investors · 7
Co-founders at NextPoint Therapeutics
GF
Gordon FreemanScientific Founder
XZ
XingXing ZangScientific Founder
Experience
- Catalio Capital ManagementCo-Founder and Managing Partnercurrent2020 — presentBaltimore, Maryland, United States
- Gigantum (acq. by nVidia)Co-Founder and Director2017 — 2022Washington D.C. Metro Area
- Camden PartnersManaging Partner, Nexus Management, L.P.2016 — 2020Washington DC-Baltimore Area
- Intelligence Advanced Research Projects ActivityProgram Manager2013 — 2017Washington D.C. Metro Area
- Gamma3 LLCPartner2012 — 2015Baltimore, MD
- Johns Hopkins UniversityAssistant Research Professor2008 — 2013Department of Electrical and Computer Engineering
- Johns Hopkins University Applied Physics LaboratoryProgram Manager, Applied Neuroscience2007 — 2013Research and Exploratory Development Department
- Global Domain PartnersPartner2006 — 2012
Skills & more
Biomedical Engineering37Signal Processing33Electronics4Machine Learning23Neuroscience13Proposal Writing3Data Analysis11Program Management13Algorithms15Science10Simulations8Systems Engineering6
+5 more
Image ProcessingMathematical ModelingResearchIntegrated Circuit DesignMatlabFrom R.'s professional profile.
Investments
Per the firm's website.
Colleagues at Catalio Capital Management, LP
Adam Riess
Venture Partner at Catalio Capital Management, LP
Alan Ashworth
Venture Partner at Catalio Capital Management, LP
Christine E. 'Kricket' Seidman
Venture Partner at Catalio Capital Management, LP
Dan Littman
Venture Partner at Catalio Capital Management, LP
David Sinclair
Venture Partner at Catalio Capital Management, LP
Diamantis Xylas
Analyst at Catalio Capital Management, LP
Frances H. Arnold
Venture Partner at Catalio Capital Management, LP
Freda Lewis-Hall
Venture Partner at Catalio Capital Management, LP
Network1
Investors connected to R. in public investor directories — a warm-intro map.
Frequently asked questions
- Who is R. Jacob Vogelstein?
- Jacob Vogelstein co-founded Catalio Capital Management and serves as Managing Partner, focusing on investments in private healthcare companies and sitting on the firm's Nexus strategy Investment Committee and Management Committee. He was previously a General Partner at Camden Partners Holdings, where he invested in biomedical technology, and earlier held faculty positions at Johns Hopkins University's Applied Physics Laboratory and Whiting School of Engineering. He holds a BSc in Bio-Electrical Engineering from Brown University and a PhD in Biomedical Engineering from the Johns Hopkins University School of Medicine.
- Where does R. Jacob Vogelstein work?
- R. Jacob Vogelstein is Managing Partner at Catalio Capital Management, LP and Board director at NextPoint Therapeutics.
- What does R. Jacob Vogelstein invest in?
- R. Jacob Vogelstein invests in Biotech, Healthtech, Medical Devices.
- What check size does R. Jacob Vogelstein write?
- R. Jacob Vogelstein typically writes checks of $100K – $5M.
- What boards does R. Jacob Vogelstein sit on?
- R. Jacob Vogelstein holds tracked board seats at Clasp, Iambic, Nextpoint, Pheast, Rhapsogen, Syndeio, Winnow Therapeutics.
- Where did R. Jacob Vogelstein go to school?
- R. Jacob Vogelstein studied at The Johns Hopkins University School of Medicine (Ph.D, Biomedical Engineering); Brown University (Sc.B, Bio-Electrical Engineering); The Park School.
Same school
Also attended The Johns Hopkins University School of Medicine43
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersStephen P. ZacharyManaging Partner at Sands Capital VenturesNamita KumariAssociate, Technical Research at Sands Capital VenturesS.K. LeeExecutive Coach at Roble Ventures
.png)
+ 37 more
Shared employers
Also worked at Camden Partners13
John TimkenCOO + CFO at SQUADRA VENTURESMeghan McGeeHead of Platform at SQUADRA VENTURESRichelle ParhamObvious Champion at Obvious VenturesGeorge C. PetrocheilosCo-Founder and Managing Partner at Catalio Capital Management, LPGrant SilowManaging Director at 25MadisonBeckie CohenAssociate at Emerald Development Managers
+ 7 more
Also worked at Johns Hopkins University80
Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Demi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesLinda CuretonBoard Member at Maryland TEDCOPaula AndreuInvestor at KfundDavid NarrowVenture Advisor at Cultivation Capital
+ 74 more
Also worked at Johns Hopkins University Applied Physics Laboratory20
Les CraigInvestor at Next Frontier CapitalKahini ShahPartner at Obvious VenturesJames GettingerCo-Founder and Managing Partner at Gutter CapitalCasey CarusoPartner at ParadigmRalph GooteeAngelRichard ChanManaging Partner at Berkeley Frontier
+ 14 more